Cargando…
Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells
More than 94% of colorectal cancer cases have mutations in one or more Wnt/β-catenin signaling pathway components. Inactivating mutations in APC or activating mutations in β-catenin (CTNNB1) lead to signaling overactivation and subsequent intestinal hyperplasia. Numerous classes of medicines derived...
Autores principales: | de Almeida, Gracielle C., Oliveira, Luiz F. S., Predes, Danilo, Fokoue, Harold H., Kuster, Ricardo M., Oliveira, Felipe L., Mendes, Fabio A., Abreu, Jose G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363889/ https://www.ncbi.nlm.nih.gov/pubmed/32669593 http://dx.doi.org/10.1038/s41598-020-68574-2 |
Ejemplares similares
-
Derricin and Derricidin Inhibit Wnt/β-Catenin Signaling and Suppress Colon Cancer Cell Growth In Vitro
por: Fonseca, Barbara F., et al.
Publicado: (2015) -
The Chalcone Lonchocarpin Inhibits Wnt/β-Catenin Signaling and Suppresses Colorectal Cancer Proliferation
por: Predes, Danilo, et al.
Publicado: (2019) -
Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer
por: Oliveira, Luiz F. S., et al.
Publicado: (2022) -
Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies
por: Amado, Nathália G., et al.
Publicado: (2014) -
The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway
por: Predes, Danilo, et al.
Publicado: (2022)